John Golubieski
2017
In 2017, John Golubieski earned a total compensation of $750.4K as Chief Financial Officer at Axsome Therapeutics.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $48,957 |
| Option Awards | $519,616 |
| Salary | $131,875 |
| Total | $750,448 |
Golubieski received $519.6K in option awards, accounting for 69% of the total pay in 2017.
Golubieski also received $50K in bonus, $49K in non-equity incentive plan and $131.9K in salary.
Rankings
In 2017, John Golubieski's compensation ranked 10,301st out of 14,666 executives tracked by ExecPay. In other words, Golubieski earned more than 29.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,301 out of 14,666 | 30th |
Division Manufacturing | 3,989 out of 5,768 | 31st |
Major group Chemicals And Allied Products | 1,403 out of 2,074 | 32nd |
Industry group Drugs | 1,140 out of 1,730 | 34th |
Industry Pharmaceutical Preparations | 889 out of 1,329 | 33rd |
Source: SEC filing on April 27, 2018.
Golubieski's colleagues
We found two more compensation records of executives who worked with John Golubieski at Axsome Therapeutics in 2017.